Bit.bio lands $103m Series B

Human cell coding company Bit.bio has secured $103 million in Series B financing.

Human cell coding company Bit.bio has secured $103 million in Series B financing. The investors include Arch Ventures, Charles River Laboratories, Foresite Capital, National Resilience Inc, Metaplanet, Puhua Capital and Tencent.

Source: Press Release